These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 15542701)
1. Involvement of signal transduction cascade via dopamine-D1 receptors in phencyclidine dependence. Noda Y; Nabeshima T Ann N Y Acad Sci; 2004 Oct; 1025():62-8. PubMed ID: 15542701 [TBL] [Abstract][Full Text] [Related]
2. Involvement of dopaminergic system in phencyclidine-induced place preference in mice pretreated with phencyclidine repeatedly. Noda Y; Miyamoto Y; Mamiya T; Kamei H; Furukawa H; Nabeshima T J Pharmacol Exp Ther; 1998 Jul; 286(1):44-51. PubMed ID: 9655840 [TBL] [Abstract][Full Text] [Related]
3. Role of catecholaminergic and cyclic AMP systems in psychological dependence on phencyclidine: a study in mutant mice. Noda Y; Nabeshima T Jpn J Pharmacol; 2000 Jun; 83(2):89-94. PubMed ID: 10928319 [TBL] [Abstract][Full Text] [Related]
4. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine. Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of dopamine D2 and D4 receptor and tyrosine hydroxylase mRNA in mice prone, or resistant, to chronic high-fat diet-induced obesity. Huang XF; Yu Y; Zavitsanou K; Han M; Storlien L Brain Res Mol Brain Res; 2005 Apr; 135(1-2):150-61. PubMed ID: 15857678 [TBL] [Abstract][Full Text] [Related]
6. The Abuse Potential of Novel Synthetic Phencyclidine Derivative 1-(1-(4-Fluorophenyl)Cyclohexyl)Piperidine (4'-F-PCP) in Rodents. Ryu IS; Kim OH; Lee YE; Kim JS; Li ZH; Kim TW; Lim RN; Lee YJ; Cheong JH; Kim HJ; Lee YS; Steffensen SC; Lee BH; Seo JW; Jang EY Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610694 [TBL] [Abstract][Full Text] [Related]
7. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway. Santanavanich C; Ebadi M; Govitrapong P J Pineal Res; 2005 Apr; 38(3):170-5. PubMed ID: 15725338 [TBL] [Abstract][Full Text] [Related]
8. Opposite regulation of cocaine-induced intracellular signaling and gene expression by dopamine D1 and D3 receptors. Zhang J; Xu M Ann N Y Acad Sci; 2006 Aug; 1074():1-12. PubMed ID: 17105899 [TBL] [Abstract][Full Text] [Related]
9. Food restriction increases NMDA receptor-mediated calcium-calmodulin kinase II and NMDA receptor/extracellular signal-regulated kinase 1/2-mediated cyclic amp response element-binding protein phosphorylation in nucleus accumbens upon D-1 dopamine receptor stimulation in rats. Haberny SL; Carr KD Neuroscience; 2005; 132(4):1035-43. PubMed ID: 15857708 [TBL] [Abstract][Full Text] [Related]
10. 4-MeO-PCP and 3-MeO-PCMo, new dissociative drugs, produce rewarding and reinforcing effects through activation of mesolimbic dopamine pathway and alteration of accumbal CREB, deltaFosB, and BDNF levels. Abiero A; Botanas CJ; Custodio RJ; Sayson LV; Kim M; Lee HJ; Kim HJ; Lee KW; Jeong Y; Seo JW; Ryu IS; Lee YS; Cheong JH Psychopharmacology (Berl); 2020 Mar; 237(3):757-772. PubMed ID: 31828394 [TBL] [Abstract][Full Text] [Related]
11. Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation. Darmopil S; Martín AB; De Diego IR; Ares S; Moratalla R Biol Psychiatry; 2009 Sep; 66(6):603-13. PubMed ID: 19520364 [TBL] [Abstract][Full Text] [Related]
12. Neuronal mechanisms of phencyclidine-induced place aversion and preference in the conditioned place preference task. Noda Y; Nabeshima T Methods Find Exp Clin Pharmacol; 1998 Sep; 20(7):607-11. PubMed ID: 9819806 [TBL] [Abstract][Full Text] [Related]
14. D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia. McLean SL; Idris NF; Woolley ML; Neill JC Eur Neuropsychopharmacol; 2009 Jun; 19(6):440-50. PubMed ID: 19268547 [TBL] [Abstract][Full Text] [Related]
15. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine. Nabeshima T; Mouri A; Murai R; Noda Y Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514 [TBL] [Abstract][Full Text] [Related]
16. The mesolimbic dopaminergic response to novel palatable food consumption increases dopamine-D1 receptor-mediated signalling with complex modifications of the DARPP-32 phosphorylation pattern. Rauggi R; Scheggi S; Cassanelli A; De Montis MG; Tagliamonte A; Gambarana C J Neurochem; 2005 Feb; 92(4):867-77. PubMed ID: 15686489 [TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of combined treatment with risperidone and galantamine on phencyclidine-induced impairment of latent visuospatial learning and memory: Role of nAChR activation-dependent increase of dopamine D1 receptor-mediated neurotransmission. Wang D; Noda Y; Zhou Y; Nitta A; Furukawa H; Nabeshima T Neuropharmacology; 2007 Sep; 53(3):379-89. PubMed ID: 17632185 [TBL] [Abstract][Full Text] [Related]
18. Effect of perinatal asphyxia on tyrosine hydroxylase and D2 and D1 dopamine receptor mRNA levels expressed during early postnatal development in rat brain. Gross J; Andersson K; Chen Y; Müller I; Andreeva N; Herrera-Marschitz M Brain Res Mol Brain Res; 2005 Apr; 134(2):275-81. PubMed ID: 15836923 [TBL] [Abstract][Full Text] [Related]